klinische Studien

Eli Lilly investiert 50 Millionen US-Dollar in Absci für KI-gestützte Haarausfall-Therapien

by

Pharmaceutical giant Eli Lilly and Company has moved to expand its footprint in generative biology by leading a $50 million investment round in Absci Corporation, a company specializing in artificial intelligence-driven drug discovery. The funding, which includes $40 million in equity, aims to accelerate the development of novel protein-based therapeutics, with early applications reportedly targeting … Read more

Silent Inflammation: The Hidden Culprit Behind Chronic Disease and New Treatment Strategies

by

For decades, the medical community has focused its most intense efforts on the visible battles of the immune system: the swelling of an infected wound, the fever of a viral onslaught, or the acute pain of an injury. However, a more insidious enemy has been operating beneath the surface, undetected by the traditional symptoms of … Read more